Interventional Cardiology: Vascular Stents

The global market for vascular stents is being driven by the increasing prevalence of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually.  This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global vascular stents products market, which includes bare-metal stents (BMSs), drug-eluting stents (DESs), and bioresorbable vascular stents/scaffolds (BVSs). Primary research querying interventional cardiologists regarding device preferences and vascular stent utilization was leveraged in the formulation of this report's forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 6.2% during 2016-21, increasing from approximately $6,535.3m in 2016 to an estimated $8,827.1m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).